Table 4.
Patient demographics and clinical characteristics in the prospective independent cohort.
| Patient characteristics | All (N = 29) | Benign (n = 1) | Malignant (n = 0) | No surgery (n = 28) | ||||
|---|---|---|---|---|---|---|---|---|
| Age | 47.0 ± 16.7 | 53.0 ± 0.0 | 0.0 ± 0.0 | 46.8 ± 16.9 | ||||
| Menopausal Status | n | %1 | n | % | n | % | n | % |
| Pre-/Peri- | 15 | 51.7 | 0 | 0 | 0 | 0 | 15 | 53.6 |
| Post- | 14 | 48.3 | 1 | 100 | 0 | 0 | 13 | 46.6 |
| Race/Ethnicity | n | % | n | % | n | % | n | % |
| White | 16 | 55.2 | 0 | 0 | 0 | 0 | 16 | 57.1 |
| African American | 1 | 3.4 | 0 | 0 | 0 | 0 | 1 | 3.6 |
| Asian | 1 | 3.4 | 0 | 0 | 0 | 0 | 1 | 3.6 |
| Hispanic | 1 | 3.4 | 0 | 0 | 0 | 0 | 1 | 3.6 |
| Sephardic Jewish | 1 | 3.4 | 0 | 0 | 0 | 0 | 1 | 3.6 |
| Unknown | 9 | 31 | 1 | 100 | 0 | 0 | 8 | 28.6 |
| MIA3G score | n | % | n | % | N | % | n | % |
| LP | 28 | 96.6 | 1 | 100 | 0 | 0 | 27 | 96.4 |
| IND | 1 | 3.4 | 0 | 0 | 0 | 0 | 1 | 3.6 |
1Percentages are calculated as a portion of the stratified group (all, benign, malignant, and no-surgery).